FibroGen
FGEN
#9996
Rank
ยฃ25.36 M
Marketcap
ยฃ6.27
Share price
-0.48%
Change (1 day)
-11.86%
Change (1 year)

Revenue for FibroGen (FGEN)

Revenue in 2025 (TTM): -ยฃ94.32 Million

According to FibroGen's latest financial reports the company's current revenue (TTM ) is -ยฃ88.58 Million. In 2024 the company made a revenue of -ยฃ77.12 Million a decrease over the revenue in the year 2023 that were of ยฃ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for FibroGen from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) -ยฃ94.32 Million22.31%
2024 -ยฃ77.12 Million-166.49%
2023 ยฃ0.11 B-0.3%
2022 ยฃ0.11 B-33.27%
2021 ยฃ0.17 B34.76%
2020 ยฃ0.12 B-33.89%
2019 ยฃ0.19 B16.63%
2018 ยฃ0.16 B58.82%
2017 ยฃ0.10 B-27.42%
2016 ยฃ0.14 B19.27%
2015 ยฃ0.12 B38.06%
2014 ยฃ88.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
ยฃ3.21 B-3,731.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ84.57 M-195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Accelerate Diagnostics
AXDX
ยฃ8.77 M-109.91%๐Ÿ‡บ๐Ÿ‡ธ USA